{"content":"<li class=\"n-box-item date-title\" data-end=\"1491451199\" data-start=\"1491364800\" data-txt=\"Monday, December 23, 2019\">Wednesday, April  5, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3255807\" data-ts=\"1491429588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDT\" target=\"_blank\">MDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255807-reuters-cardinal-health-near-6b-deal-for-medtronics-medical-supplies-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Cardinal Health near $6B deal for Medtronic&#39;s medical-supplies unit</a></h4><ul>     <li>Medtronic (<a href=\"http://seekingalpha.com/symbol/MDT\" target=\"_blank\">MDT</a> <font color='red'>-0.5%</font>) is <font color='green'>up 1.6%</font> after hours after a Reuters report that Cardinal Health (<a href=\"http://seekingalpha.com/symbol/CAH\" target=\"_blank\">CAH</a> <font color='green'>+0.1%</font>) is <a href=\"http://www.reuters.com/article/us-medtronic-m-a-cardinal-health-idUSKBN1772VH\" target=\"_blank\">close to a $6B deal</a> for Medtronic's medical supplies business.</li><li>The two are in exclusive talks, Reuters says, and a deal could come later this month.</li><li>Cardinal would get a boost to its medical-products business -- it added a portfolio of devices in an acquisition of J&amp;J's Cordis for $2B -- while Medtronic would streamline its portfolio after <a href=\"https://seekingalpha.com/news/2245746-medtronic-completes-covidien-transaction\" target=\"_blank\">taking on Covidien</a> for $42.9B in 2014.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255807\" data-linked=\"Reuters: Cardinal Health near $6B deal for Medtronic&#39;s medical-supplies unit\" data-tweet=\"$MDT $MDT $CAH - Reuters: Cardinal Health near $6B deal for Medtronic&#39;s medical-supplies unit https://seekingalpha.com/news/3255807-reuters-cardinal-health-near-6b-deal-for-medtronics-medical-supplies-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3255807-reuters-cardinal-health-near-6b-deal-for-medtronics-medical-supplies-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255804\" data-ts=\"1491428088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255804-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/YUMC' title='Yum China'>YUMC</a> <font color='green'>+9.7%</font>. <a href='https://seekingalpha.com/symbol/KOPN' title='Kopin Corporation'>KOPN</a> <font color='green'>+5.5%</font>. <a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals'>MACK</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/JAZZ' title='Jazz Pharmaceuticals, Inc.'>JAZZ</a> <font color='green'>+4.5%</font>. <a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='green'>+3.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/CAFD' title='8point3 Energy Partners LP'>CAFD</a> <font color='red'>-14.5%</font>. <a href='https://seekingalpha.com/symbol/SYNC' title='Synacor'>SYNC</a> <font color='red'>-13.3%</font>. <a href='https://seekingalpha.com/symbol/RECN' title='Resources Connection, Inc.'>RECN</a> <font color='red'>-9.0%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='red'>-5.5%</font>. <a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a> <font color='red'>-2.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255804\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$YUMC $KOPN $MACK - After Hours Gainers / Losers https://seekingalpha.com/news/3255804-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3255804-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255801\" data-ts=\"1491427108\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255801-mgm-to-buy-out-viacom-lions-gate-from-epix-for-1_03b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGM to buy out Viacom, Lions Gate from Epix for $1.03B</a></h4><ul>   <li>As <a href=\"https://seekingalpha.com/news/3250234-reuters-mgm-discussing-buying-epix-partners-viacom-lions-gate\" target=\"_blank\">previously speculated</a>, MGM Holdings is going to <a href=\"http://uk.reuters.com/article/viacom-epix-sale-idUKL3N1HD4IW\" target=\"_blank\">buy out its partners</a> in premium TV channel Epix, paying $1.03B for the 81% it doesn't own.</li>    <li>That means taking the 50% stake from Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+0.3%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>-0.5%</font>) and the 31.2% stake from Lions Gate Entertainment (<a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='red'>-2.7%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='red'>-2.3%</font>) for that sum.</li>    <li>MGM will get a boost to its TV business with full control of the channel to leverage its classic library. Viacom can reduce debt and Lions Gate can focus after its acquisition of Starz.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+0.3%</font>; <a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='green'>+1.1%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='green'>+2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255801\" data-linked=\"MGM to buy out Viacom, Lions Gate from Epix for $1.03B\" data-tweet=\"$VIA $VIA $VIAB - MGM to buy out Viacom, Lions Gate from Epix for $1.03B https://seekingalpha.com/news/3255801-mgm-to-buy-out-viacom-lions-gate-from-epix-for-1_03b?source=tweet\" data-url=\"https://seekingalpha.com/news/3255801-mgm-to-buy-out-viacom-lions-gate-from-epix-for-1_03b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255789\" data-ts=\"1491424350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUMC\" target=\"_blank\">YUMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255789-yum-china-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yum China beats by $0.06, beats on revenue</a></h4><ul><li>Yum China (NYSE:<a href='https://seekingalpha.com/symbol/YUMC' title='Yum China'>YUMC</a>): FQ1 EPS of $0.44 <font color='green'>beats by $0.06</font>.</li><li>Revenue of $1.28B (-1.5% Y/Y) <font color='green'>beats by $10M</font>.</li><li>Shares <font color='green'>+12%</font>.</li><li><a href='https://seekingalpha.com/pr/16792243-yum-china-achieved-strong-first-quarter-store-sales-growth-1-percent-operating-profit-grew-22'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3255789\" data-linked=\"Yum China beats by $0.06, beats on revenue\" data-tweet=\"$YUMC - Yum China beats by $0.06, beats on revenue https://seekingalpha.com/news/3255789-yum-china-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3255789-yum-china-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255772\" data-ts=\"1491422883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSEC\" target=\"_blank\">PSEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255772-prospect-capitalminus-1_3-on-convertible-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prospect Capital -1.3% on convertible note offering</a></h4><ul><li>Part of the proceeds from <a href=\"https://seekingalpha.com/pr/16792178-prospect-capital-announces-public-offering-convertible-notes-due-2022\" target=\"_blank\">the new 5-year paper </a>will be used to repurchase from time to time 5.375% convertible notes due this year and 5.75% convertible notes due in 2018.</li><li>Goldman is underwriting.</li><li><a href='https://seekingalpha.com/symbol/PSEC' title='Prospect Capital Corporation'>PSEC</a>&nbsp;<font color='red'>-1.3%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3255772\" data-linked=\"Prospect Capital -1.3% on convertible note offering\" data-tweet=\"$PSEC - Prospect Capital -1.3% on convertible note offering https://seekingalpha.com/news/3255772-prospect-capitalminus-1_3-on-convertible-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3255772-prospect-capitalminus-1_3-on-convertible-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255763\" data-ts=\"1491421756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYB\" target=\"_blank\">LYB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255763-lyondellbasellminus-2_5-after-saying-may-borrow-18b-for-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LyondellBasell -2.5% after saying it may borrow $18B for M&amp;A</a></h4><ul>     <li>LyondellBasell (<a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a> <font color='red'>-2.5%</font>) tumbles into the close after saying during its investor day presentation that it is <a href=\"http://thefly.com/landingPageNews.php?id=2530328&amp;headline=LYB-LyondellBasell-falls-after-saying-may-borrow-B-for-MA-\" target=\"_blank\">evaluating borrowing up to $18B</a> for acquisitions.</li>     <li>During its presentation, LYB management discussed keeping acquisitions in its existing value chain, but has no plans to acquire any specialty chemical companies, according to TheFly.com.</li>     <li>LYB also reportedly says it plans to maintain its dividend and will be more opportunistic on share repurchases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255763\" data-linked=\"LyondellBasell -2.5% after saying it may borrow $18B for M&amp;A\" data-tweet=\"$LYB - LyondellBasell -2.5% after saying it may borrow $18B for M&amp;A https://seekingalpha.com/news/3255763-lyondellbasellminus-2_5-after-saying-may-borrow-18b-for-m?source=tweet\" data-url=\"https://seekingalpha.com/news/3255763-lyondellbasellminus-2_5-after-saying-may-borrow-18b-for-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255760\" data-ts=\"1491420960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLUG\" target=\"_blank\">PLUG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255760-plug-powerplus-66-after-amazon-acquires-right-to-buy-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plug Power +66% after Amazon acquires right to buy stake</a></h4><ul>     <li>Plug Power (<a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+66.2%</font>) pushes out to 52-week highs on its <a href=\"https://seekingalpha.com/news/3255610-plug-rockets-amazon-deal\" target=\"_blank\">surprise deal</a> to supply batteries to power forklifts used by Amazon in the online retailer's warehouses in exchange for the right to buy up to 23% of the company.</li>     <li>Raymond James analyst Pavel Molchanov sees  the deal as one of the few <a href=\"http://www.reuters.com/article/us-amazon-com-plug-power-idUSKBN1771BB\" target=\"_blank\">bright spots</a> that highlighted the potential for growth in the fuel cell industry, which had lost favor with investors as the technology failed to gain traction; Plug itself lost more than two-thirds of its market value since Q1 2014, when it was valued at more than $1B.</li>     <li>Molchanov also notes that Plug's narrow focus of powering forklifts  with fuel cells essentially makes the company the only player in the  market.</li>     <li>Other fuel cell companies are higher: <a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a> <font color='green'>+5%</font>, <a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='green'>+7.2%</font>, <a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+0.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255760\" data-linked=\"Plug Power +66% after Amazon acquires right to buy stake\" data-tweet=\"$PLUG $PLUG $HYGS - Plug Power +66% after Amazon acquires right to buy stake https://seekingalpha.com/news/3255760-plug-powerplus-66-after-amazon-acquires-right-to-buy-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3255760-plug-powerplus-66-after-amazon-acquires-right-to-buy-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255758\" data-ts=\"1491420871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255758-reversal-stocks-give-up-nice-gains-turn-lower-late-in-session\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reversal: Stocks give up nice gains, turn lower late in session</a></h4><ul><li><font color='green'>Up nearly 1%&nbsp;</font>earlier, the major averages are all in the red 30 minutes before the close, led by a near-2% swing in the banks. The <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> and <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> are now each<font color='red'> off more than 1.5%</font>.</li><li>The S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) is&nbsp;<font color='red'>down 0.3%</font>, and the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='PowerShares QQQ Trust ETF'>QQQ</a>)<font color='red'> 0.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255758\" data-linked=\"Reversal: Stocks give up nice gains, turn lower late in session\" data-tweet=\"$KRE $KBE $SPY - Reversal: Stocks give up nice gains, turn lower late in session https://seekingalpha.com/news/3255758-reversal-stocks-give-up-nice-gains-turn-lower-late-in-session?source=tweet\" data-url=\"https://seekingalpha.com/news/3255758-reversal-stocks-give-up-nice-gains-turn-lower-late-in-session\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255753\" data-ts=\"1491419451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVD\" target=\"_blank\">AVD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255753-american-vanguardplus-6_6-on-deal-to-buy-chemchina-crop-protection-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Vanguard +6.6% on deal to buy ChemChina crop protection assets</a></h4><ul>     <li>American Vanguard (<a href='https://seekingalpha.com/symbol/AVD' title='American Vanguard Corporation'>AVD</a> <font color='green'>+6.6%</font>) surges after <a href=\"https://seekingalpha.com/pr/16791562-american-vanguard-enters-agreement-adama-acquire-certain-crop-protection-assets-u-s\" target=\"_blank\">agreeing to acquire</a> U.S. assets related to the three  crop protection product lines - Abamectin, Chlorothalonil and Paraquat -  from ChemChina unit Adama Agricultural Solutions; terms are not disclosed.</li><li>The deal is part of ChemChina's <a href=\"https://seekingalpha.com/news/3255541-chemchina-wins-u-s-approval-syngenta-takeover\" target=\"_blank\">agreement with the FTC</a> that requires the company to divest the assets as a  pre-condition for its proposed acquisition of Syngenta.</li>     <li>SunTrust analyst James Sheehan says the products <a href=\"http://thefly.com/landingPageNews.php?id=2530134&amp;headline=AVD-American-Vanguard-to-benefit-from-new-products--says-SunTrust\" target=\"_blank\">will fit in well</a> with AVD's existing portfolio and estimates the deal will raise EPS by $0.10-$0.15; he keeps a Buy rating and $18 price target on the shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255753\" data-linked=\"American Vanguard +6.6% on deal to buy ChemChina crop protection assets\" data-tweet=\"$AVD - American Vanguard +6.6% on deal to buy ChemChina crop protection assets https://seekingalpha.com/news/3255753-american-vanguardplus-6_6-on-deal-to-buy-chemchina-crop-protection-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3255753-american-vanguardplus-6_6-on-deal-to-buy-chemchina-crop-protection-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255750\" data-ts=\"1491418927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255750-applied-optoelectronicsminus-9-rayjay-defends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Optoelectronics -9%; RayJay defends</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>We lack a good explanation of the cause of the decline, says Raymond James, but we know what it isn't: 3D delays should not be affecting the stock as Applied (<a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='red'>-9%</font>) isn't involved in recent initiatives to secure design positions for 3D sensing in mobile devices.</li><li>Lumentum Holdings (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='red'>-3.6%</font>), Finisar (<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='red'>-4.8%</font>), Acacia Communications (<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a> <font color='red'>-2.9%</font>), NeoPhotonics (<a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='red'>-0.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255750\" data-linked=\"Applied Optoelectronics -9%; RayJay defends\" data-tweet=\"$AAOI $AAOI $LITE - Applied Optoelectronics -9%; RayJay defends https://seekingalpha.com/news/3255750-applied-optoelectronicsminus-9-rayjay-defends?source=tweet\" data-url=\"https://seekingalpha.com/news/3255750-applied-optoelectronicsminus-9-rayjay-defends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>154&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255747\" data-ts=\"1491418804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255747-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+72%</font>. <a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='green'>+9%</font>. MSDI <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems Inc.'>MITK</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> COOL <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255747\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$PLUG $BVSN $SCON - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3255747-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3255747-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255749\" data-ts=\"1491418634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SU\" target=\"_blank\">SU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255749-suncor-energy-added-to-conviction-buy-list-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Suncor Energy added to Conviction Buy List at Goldman</a></h4><ul>     <li>Suncor Energy (<a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a> <font color='green'>+1.7%</font>) is higher after Goldman Sachs <a href=\"http://www.nasdaq.com/article/suncor-stock-upgraded-what-you-need-to-know-cm770335\" target=\"_blank\">adds the stock to its Conviction Buy List</a> and assigns a $38 price target, forecasting that revenue from its new Hebron field and Fort Hills projects will mean more production and cash flow.</li>     <li>Goldman believes SU has the ability to not just break even, but generate \"strong\" free cash flow, perhaps even at lower oil prices following the company's strides in lowering its cost of production in recent years; the firm thinks SU would apply the cash to stock buybacks and dividend hikes.</li>     <li>Even with the cost advantage, Goldman believes investors are undervaluing SU shares, and that the stock trades at an attractive discount to peers.</li><li><a href=\"https://seekingalpha.com/news/3255732-goldman-picks-favorites-oil-and-gas-refiners\" target=\"_blank\">Other Goldman favorites</a> among oil and gas producers and refiners are Marathon Petroleum, Valero Energy, Husky Energy and Chevron.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255749\" data-linked=\"Suncor Energy added to Conviction Buy List at Goldman\" data-tweet=\"$SU - Suncor Energy added to Conviction Buy List at Goldman https://seekingalpha.com/news/3255749-suncor-energy-added-to-conviction-buy-list-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/3255749-suncor-energy-added-to-conviction-buy-list-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255746\" data-ts=\"1491417867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGI\" target=\"_blank\">CGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255746-celadon-group-falls-after-critical-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celadon Group falls after critical report</a></h4><ul><li>Celadon (<a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a> <font color='red'>-10.4%</font>) crumbles after Prescience Point Research issues a scathing report on the company.</li><li>In the first line of its report, the short-selling firm says that it believes Celadon is a \"house of cards\" on the brink of collapse. Sell-side analysts covering Celadon are also given a brutal assessment.</li><li>The price target from Prescience on Celadon is taken down to $0.00.</li><li><a href=\"https://seekingalpha.com/article/4060487-celadon-group-story-ends-chapter-11\" target=\"_blank\">Full Prescience Point report</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3255746\" data-linked=\"Celadon Group falls after critical report\" data-tweet=\"$CGI - Celadon Group falls after critical report https://seekingalpha.com/news/3255746-celadon-group-falls-after-critical-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3255746-celadon-group-falls-after-critical-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255744\" data-ts=\"1491417335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACH\" target=\"_blank\">ACH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255744-ft-chinalco-to-boost-investment-flagship-peru-copper-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FT: Chinalco to boost investment at flagship Peru copper mine</a></h4><ul>     <li>Chinalco (<a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Ltd'>ACH</a> <font color='green'>+2.5%</font>) says it will <a href=\"https://www.ft.com/content/3c7b1df6-04dd-374e-aa9b-8588e8222802\" target=\"_blank\">step up investment</a> at its key Toromocho mining project in Peru, as the country becomes an increasingly important supplier of copper to China.</li>     <li>Chinalco China Copper president Wu Jiangqiang tells <em>Financial Times</em> that he expects the mine to produce 180K-190K metric tons of copper this year, up 13% Y/Y, after output last year reached only 168K tons, failing to meet the company's copper output target of 182K tons.</li>     <li>Wu says ACH will start to build the second phase of Toromocho \"very soon,\" which analysts at Citi estimate will add another 70K metric tons/year to the project.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255744\" data-linked=\"FT: Chinalco to boost investment at flagship Peru copper mine\" data-tweet=\"$ACH - FT: Chinalco to boost investment at flagship Peru copper mine https://seekingalpha.com/news/3255744-ft-chinalco-to-boost-investment-flagship-peru-copper-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3255744-ft-chinalco-to-boost-investment-flagship-peru-copper-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255740\" data-ts=\"1491415873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255740-youtube-tv-launches-live-service-in-major-markets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YouTube TV launches live service in major markets</a></h4><ul>   <li>YouTube TV (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.8%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.8%</font>) <a href=\"https://youtube.googleblog.com/2017/04/youtube-tv-is-now-live.html\" target=\"_blank\">has launched</a> in major metro markets, offering cord-cutters a bundle of live programming at $35/month.</li>    <li>Viewers in New York, Los Angeles, San Francisco area, Chicago and Philadelphia are eligible to jump on board, and the company will roll out more cities along the way.</li>    <li>In the battle for skinny bundling, YouTube's package features more than 50 channels, with broadcast networks as expected, along with ESPN (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>), Fox Sports nets (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) and Comcast SportsNet (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>), and FX, USA, Disney Channel, Bravo, MSNBC, and Fox News.</li>    <li>It also offers a cloud DVR with unlimited storage (but holding programs only for nine months). Six accounts per household can customize DVR storage, and three simultaneous streams are allowed per household.</li>    <li>YouTube TV will soon offer AMC networks (<a href='https://seekingalpha.com/symbol/AMCX' title='AMC Networks Inc.'>AMCX</a> <font color='green'>+3.2%</font>) -- drawing into sharper relief the differences in long-term prospects for smaller network bundles left out of the new live-streaming offerings (in <a href=\"https://twitter.com/shalini/status/849679603262267392\" target=\"_blank\">YouTube's case</a>, excluding Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>), Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>), Discovery (NASDAQ:<a href='https://seekingalpha.com/symbol/DISCA' title='Discovery Inc A'>DISCA</a>) and Scripps Networks (NYSE:<a href='https://seekingalpha.com/symbol/SNI' title='Scripps Networks Interactive, Inc.'>SNI</a>)).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255740\" data-linked=\"YouTube TV launches live service in major markets\" data-tweet=\"$GOOG $GOOG $GOOGL - YouTube TV launches live service in major markets https://seekingalpha.com/news/3255740-youtube-tv-launches-live-service-in-major-markets?source=tweet\" data-url=\"https://seekingalpha.com/news/3255740-youtube-tv-launches-live-service-in-major-markets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255816\" data-ts=\"1491415166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255816-fuelcell-energy-unveils-grid-resiliency-project-pseg-long-island\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell Energy unveils grid resiliency project with PSEG Long Island</a></h4><ul>     <li>FuelCell Energy (<a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='green'>+5.5%</font>) is higher, in part due to its <a href=\"https://seekingalpha.com/pr/16791433-fuelcell-energy-announces-grid-resiliency-project-pseg-long-island\" target=\"_blank\">new multi-year agreement</a> with a Public Service Enterprise Group (<a href='https://seekingalpha.com/symbol/PEG' title='Public Service Enterprise Group Inc.'>PEG</a> <font color='green'>+0.4%</font>) subsidiary to supply an electrical substation on Long Island, N.Y., with electricity using one of its SureSource 1500 fuel cell plants.</li>     <li>FCEL expects the fuel cell power plant to lower CO2 emissions by ~3,300 tons/year while also reducing its annual output of nitrogen oxide and sulfuric oxide by five tons and one ton, respectively.</li>     <li>Shares also are likely rallying alongside Plug Power (<a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+73.1%</font>), which will deploy its fuel cells and hydrogen technology through Amazon's fulfillment network.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255816\" data-linked=\"FuelCell Energy unveils grid resiliency project with PSEG Long Island\" data-tweet=\"$FCEL $FCEL $PEG - FuelCell Energy unveils grid resiliency project with PSEG Long Island https://seekingalpha.com/news/3255816-fuelcell-energy-unveils-grid-resiliency-project-pseg-long-island?source=tweet\" data-url=\"https://seekingalpha.com/news/3255816-fuelcell-energy-unveils-grid-resiliency-project-pseg-long-island\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255733\" data-ts=\"1491414352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255733-energy-materials-top-gainers-losers-of-1-45-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 1:45 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MVO' title='MV Oil Trust'>MVO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AVD' title='American Vanguard Corporation'>AVD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/KWR' title='Quaker Chemical Corporation'>KWR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AAU' title='Almaden Minerals Ltd'>AAU</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NAK' title='Northern Dynasty Minerals Ltd'>NAK</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255733\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 1:45 pm\" data-tweet=\"$VOC $MVO $AVD - Energy/Materials - Top Gainers / Losers as of 1:45 pm https://seekingalpha.com/news/3255733-energy-materials-top-gainers-losers-of-1-45-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3255733-energy-materials-top-gainers-losers-of-1-45-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255730\" data-ts=\"1491413197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTDR\" target=\"_blank\">MTDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255730-matador-resourcesplus-2-on-exxon-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Matador Resources +2% on Exxon takeover chatter</a></h4><ul>     <li>Matador Resources (<a href='https://seekingalpha.com/symbol/MTDR' title='Matador Resources'>MTDR</a> <font color='green'>+1.8%</font>) pops higher amid <a href=\"http://cnafinance.com/matador-resources-mtdr-stock-gaining-on-interest-from-exxon-mobil-xom/14678\" target=\"_blank\">speculation</a> the company could be targeted for acquisition by Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='green'>+1.2%</font>).</li><li>There is no known basis for the rumor at present, and no specifics are available, but shares are higher on heavier than normal volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255730\" data-linked=\"Matador Resources +2% on Exxon takeover chatter\" data-tweet=\"$MTDR $MTDR $XOM - Matador Resources +2% on Exxon takeover chatter https://seekingalpha.com/news/3255730-matador-resourcesplus-2-on-exxon-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3255730-matador-resourcesplus-2-on-exxon-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255717\" data-ts=\"1491411638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255717-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BKJ' title='Bancorp of New Jersey, Inc.'>BKJ</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CFBK' title='Central Federal Corporation'>CFBK</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CPSS' title='Consumer Portfolio Services, Inc.'>CPSS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a> <font color='red'>-8%</font>. FSFR <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255717\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$BKJ $CFBK $CPSS - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3255717-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3255717-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255712\" data-ts=\"1491411338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255712-neovasc-spikes-on-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc spikes on upgrade</a></h4><ul><li>Neovasc (<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='green'>+15%</font>) perks up on average volume on the heels of an upgrade to Buy from a sell-side firm.</li><li>The company's main product is the <a href=\"http://www.neovasc.com/products/neovasc-tiara/\" target=\"_blank\">Tiara</a>, a transcatheter device designed to treat mitral regurgitation.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3255712\" data-linked=\"Neovasc spikes on upgrade\" data-tweet=\"$NVCN - Neovasc spikes on upgrade https://seekingalpha.com/news/3255712-neovasc-spikes-on-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3255712-neovasc-spikes-on-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255713\" data-ts=\"1491411215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255713-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+64%</font>. <a href='https://seekingalpha.com/symbol/CALI' title='China Auto Logistics Inc.'>OTC:CALI</a> <font color='green'>+38%</font>. MSDI <font color='green'>+25%</font>. NEOT <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a> <font color='green'>+19%</font>. AUXO <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/EVI' title='EnviroStar, Inc.'>EVI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/RCMT' title='RCM Technologies, Inc.'>RCMT</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/UNIS' title='Unilife Corporation'>UNIS</a> <font color='red'>-76%</font>. <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CXRX-OLD' title='Concordia International Corp'>CXRX-OLD</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='red'>-12%</font>. COOL <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>&nbsp;<font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255713\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$PLUG $CALI $INNT - Midday Gainers / Losers https://seekingalpha.com/news/3255713-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3255713-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255714\" data-ts=\"1491410966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLT\" target=\"_blank\">FLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255714-fleetcor-defended-wells-fargo-against-citron-short-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FleetCor defended by Wells Fargo against Citron short report</a></h4><ul>     <li>FleetCor Technologies (<a href='https://seekingalpha.com/symbol/FLT' title='FleetCor Technologies, Inc.'>FLT</a> <font color='green'>+1.8%</font>) recoups part of <a href=\"https://seekingalpha.com/news/3255471-fleetcor-minus-5-percent-citron-research-comes-negative\" target=\"_blank\">yesterday's 5% drubbing</a> caused by Citron's negative report that called FLT a \"predatory company.\"</li>     <li>The report said FLT generates 56% of its revenue from customers, rather than from merchants, while competitor WEX has a fee structure that generates only 12% of total revenue from customers.</li>     <li>Wells Fargo's Timothy Will <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9265298/fleetcor-defended-by-wells-fargo-against-citron-short-re\" target=\"_blank\">defends FLT</a>, reiterating his Outperform rating and setting a valuation range of $170-$180, saying WEX generated at least 34% of its consolidated revenue in 2016 from customers, including 39% within the fleet segment; although FLT&rsquo;s figure is much higher, it represents a &ldquo;more comparable mix to WEX.&rdquo;</li>     <li>Will says that while FLT&rsquo;s generated 44% more revenue per transaction in its fuel card business than WEX in 2016, &ldquo;we believe the premium is explained by business mix and not company-specific fee structures.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3255714\" data-linked=\"FleetCor defended by Wells Fargo against Citron short report\" data-tweet=\"$FLT - FleetCor defended by Wells Fargo against Citron short report https://seekingalpha.com/news/3255714-fleetcor-defended-wells-fargo-against-citron-short-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3255714-fleetcor-defended-wells-fargo-against-citron-short-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255711\" data-ts=\"1491410639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGI\" target=\"_blank\">CGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255711-celadon-tumbles-15-after-short-seller-calls-stock-zero\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celadon tumbles 15% after short-seller calls stock a zero</a></h4><ul><li>Over 95% of Celadon's (<a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a> <font color='red'>-15.2%</font>) reported tangible book value does not exist, says Prescience Point Research Group. They estimate TBV at no more than $0.42 per share.</li><li><a href=\"http://www.presciencepoint.com/reports/Celadon-Group-CGI.pdf\" target=\"_blank\">Full report here</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3255711\" data-linked=\"Celadon tumbles 15% after short-seller calls stock a zero\" data-tweet=\"$CGI - Celadon tumbles 15% after short-seller calls stock a zero https://seekingalpha.com/news/3255711-celadon-tumbles-15-after-short-seller-calls-stock-zero?source=tweet\" data-url=\"https://seekingalpha.com/news/3255711-celadon-tumbles-15-after-short-seller-calls-stock-zero\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255709\" data-ts=\"1491410151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCT\" target=\"_blank\">ARCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255709-alcobra-thumbs-down-on-request-from-activist-investor-for-special-meeting-to-replace-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcobra thumbs down on request from activist investor for special meeting to replace board; shares off 4%</a></h4><ul><li>Alcobra (ADHD <font color='red'>-3.7%</font>) has <a href=\"https://seekingalpha.com/filing/3491983\" target=\"_blank\">rejected a request</a> from institutional investor Brosh Capital to hold an Extraordinary General Meeting of Shareholders to vote on, among other items, replacing the board of directors.</li><li>In a letter, Chairman Howard Rosen said that, while the company \"welcomes the involvement of shareholders in [its] strategic path, this welcoming approach should not be mistaken as encouragement for legally insufficient requests and factually baseless assertions\" such as those made in Brosh's March 16 letters. He adds that complying to its request would violate Alcobra's Articles of Incorporation.</li><li>Brosh is agitating for changes that it believes will boost shareholder value.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255709\" data-linked=\"Alcobra thumbs down on request from activist investor for special meeting to replace board; shares off 4%\" data-tweet=\"$ARCT - Alcobra thumbs down on request from activist investor for special meeting to replace board; shares off 4% https://seekingalpha.com/news/3255709-alcobra-thumbs-down-on-request-from-activist-investor-for-special-meeting-to-replace-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3255709-alcobra-thumbs-down-on-request-from-activist-investor-for-special-meeting-to-replace-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255706\" data-ts=\"1491408977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALR\" target=\"_blank\">ALR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255706-alere-up-8-ruling-approaches-on-abbott-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alere up 8% as ruling approaches on Abbott case</a></h4><ul><li>Alere (<a href='https://seekingalpha.com/symbol/ALR' title='Alere Inc.'>ALR</a> <font color='green'>+7.9%</font>) spikes on more than double normal volume ahead of the expected ruling on its dispute with would-be acquirer Abbott (<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color='red'>-0.1%</font>). Investors clearly expect good news for the point-of-care diagnostics firm. Abbott has been trying to back out of the $5.8B deal due to a range of problems and loss of value.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3253381-alere-3-percent-investors-anticipate-improved-prospects-favorable-outcome-abbott-based-ruling\" target=\"_blank\">Alere up 3% as investors anticipate improved prospects for favorable outcome with Abbott based on ruling by judge in different case</a>&nbsp;(March 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255706\" data-linked=\"Alere up 8% as ruling approaches on Abbott case\" data-tweet=\"$ALR $ALR $ABT - Alere up 8% as ruling approaches on Abbott case https://seekingalpha.com/news/3255706-alere-up-8-ruling-approaches-on-abbott-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3255706-alere-up-8-ruling-approaches-on-abbott-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255703\" data-ts=\"1491408010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255703-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/LNDC' title='Landec Corporation'>LNDC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255703\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FFHL $LNDC $SEED - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3255703-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3255703-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255689\" data-ts=\"1491408000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255689-taser-now-axon-offers-free-body-cameras\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taser (now Axon) offers free body cameras</a></h4><ul><li>Taser (TASR <font color='green'>+4.8%</font>) is launching a new program to equip every police officer in America with an Axon Body 2 camera, Evidence.com \"Unlimited Pro\" license and other support to police departments free of cost for one year.</li><li>\"We are going 'all-in' to empower police officers to more safely and effectively do their jobs and drive important social change,\" said CEO Rick Smith.</li><li>Reflecting the announcement, Taser will change its name to Axon and begin trading on the Nasdaq tomorrow under ticker symbol \"AAXN.\"</li><li>Outstanding stock certificates will not be affected by the name change and won't need to be exchanged.</li><li>Digital Ally (<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color='red'>-2.4%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255645-taser-nearly-5-percent-ahead-big-announcement\" target=\"_blank\">Taser up nearly 5% ahead of big announcement</a> (Apr. 05 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255689\" data-linked=\"Taser (now Axon) offers free body cameras\" data-tweet=\"$AAXN $AAXN $DGLY - Taser (now Axon) offers free body cameras https://seekingalpha.com/news/3255689-taser-now-axon-offers-free-body-cameras?source=tweet\" data-url=\"https://seekingalpha.com/news/3255689-taser-now-axon-offers-free-body-cameras\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255699\" data-ts=\"1491407047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMFW\" target=\"_blank\">AMFW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255699-wood-group-hikes-estimate-of-savings-from-proposed-amec-takeover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wood Group hikes estimate of savings from proposed Amec takeover</a></h4><ul>     <li>Amec Foster Wheeler (<a href='https://seekingalpha.com/symbol/AMFW' title='Amec Foster Wheeler plc'>AMFW</a> <font color='green'>+2.6%</font>) is higher after would-be acquirer John Wood Group (<a href='https://seekingalpha.com/symbol/WDGJF' title='Wood Group &#40;John&#41; Plc.'>OTCPK:WDGJF</a>)&nbsp; <a href=\"https://www.ft.com/content/43edabf4-19e0-11e7-a266-12672483791a\" target=\"_blank\">increases the savings it expects</a> to make from its <a href=\"https://seekingalpha.com/news/3250541-amec-foster-wheeler-agrees-takeover-offer-john-wood\" target=\"_blank\">proposed &pound;2.2B takeover</a> by more than a third, as it strives to persuade shareholders of the merits of the deal.</li>     <li>Wood forecasts at least &pound;150M/year of synergies three years after completing the tie-up, up from its original estimate of at least &pound;110M/year.</li><li>Wood says the cost savings would be achieved by cutting duplicated management roles and closing overlapping offices, but adds that a one-time &pound;190M cost would be needed to implement them.</li><li>Analysts have noted that the combined companies would create a powerful force in the U.K. North Sea, with a market share of as much as 60% in areas such as maintenance and modifications.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255699\" data-linked=\"Wood Group hikes estimate of savings from proposed Amec takeover\" data-tweet=\"$AMFW $AMFW $WDGJF - Wood Group hikes estimate of savings from proposed Amec takeover https://seekingalpha.com/news/3255699-wood-group-hikes-estimate-of-savings-from-proposed-amec-takeover?source=tweet\" data-url=\"https://seekingalpha.com/news/3255699-wood-group-hikes-estimate-of-savings-from-proposed-amec-takeover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255694\" data-ts=\"1491406870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255694-ubs-cuts-outlook-on-astrazeneca-to-neutral-shares-ease-over-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS cuts outlook on AstraZeneca to Neutral; shares ease over 1%</a></h4><ul><li>AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='red'>-1.6%</font>) was down&nbsp;<font color='red'>2%</font>&nbsp;earlier in the session on the heels of a downgrade to Neutral by UBS. Analyst Jack Scannell says the risk/reward from its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02453282?term=astrazeneca&amp;titles=mystic&amp;rank=1\" target=\"_blank\">MYSTIC </a>study assessing durvalumab in non-small lung cancer has changed from positive to \"balanced\" saying that overall survival data will not be available until 2018 and progression-free survival &#40;PFS&#41; results mid-year. He believes positive PFS data will not make the product a clear winner, but weak data could brand it a loser.</li><li>He adds that the company is generating higher revenues by selling assets and making deals in order to support greater investment in its pipeline and new drugs.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3240816-shore-sees-little-reason-astrazeneca-past-ex-d-date-cites-disappointment-risk-outcome-late\" target=\"_blank\">Shore sees \"little reason\" to own AstraZeneca past ex-d date, cites disappointment risk with outcome of late-stage study of durvalumab in lung cancer</a> (Feb. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255694\" data-linked=\"UBS cuts outlook on AstraZeneca to Neutral; shares ease over 1%\" data-tweet=\"$AZN - UBS cuts outlook on AstraZeneca to Neutral; shares ease over 1% https://seekingalpha.com/news/3255694-ubs-cuts-outlook-on-astrazeneca-to-neutral-shares-ease-over-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3255694-ubs-cuts-outlook-on-astrazeneca-to-neutral-shares-ease-over-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255691\" data-ts=\"1491405922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVFM\" target=\"_blank\">EVFM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255691-neothetics-nabs-eighth-patent-covering-lead-candidate-lipominus-202-shares-up-29\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neothetics nabs eighth patent covering lead candidate LIPO-202; shares up 29%</a></h4><ul><li>Thinly traded nano cap Neothetics (NEOT <font color='green'>+29%</font>) heads north on a healthy 55x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16791325-neothetics-announces-issuance-uspto-eighth-patent-directed-lipominus-202-lead-clinical-asset\" target=\"_blank\">announcement </a>that the USPTO has issued a new patent, the eighth, protecting lead product candidate LIPO-202.</li><li>U.S. Patent No. 9,597,531 covers methods of using LIPO-202 and other agents for the reduction of fat accumulation. The patent will be valid through at least Q4 2031.</li><li><a href=\"http://www.neothetics.com/lipo.html\" target=\"_blank\">LIPO-202</a>&nbsp;is an injectable formulation of salmeterol xinafoate, a well-known long-acting beta2-adrenergic receptor agonist used in several commercially available inhaled drugs, including GlaxoSmithKline's SEREVENT DISKUS. Earlier studies suggested that salmeterol xinafoate activates beta2-adrenergic receptors in fat cells, triggering the metabolism of triglycerides and shrinking them via a process called lipolysis. It is currently in <a href=\"https://clinicaltrials.gov/ct2/show/NCT03005717?term=lipo-202&amp;rank=1\" target=\"_blank\">Phase 2 development</a> for the reduction of submental subcutaneous fat (fat under the chin).</li></ul><div class=\"tiny-share-widget\" data-id=\"3255691\" data-linked=\"Neothetics nabs eighth patent covering lead candidate LIPO-202; shares up 29%\" data-tweet=\"$EVFM - Neothetics nabs eighth patent covering lead candidate LIPO-202; shares up 29% https://seekingalpha.com/news/3255691-neothetics-nabs-eighth-patent-covering-lead-candidate-lipominus-202-shares-up-29?source=tweet\" data-url=\"https://seekingalpha.com/news/3255691-neothetics-nabs-eighth-patent-covering-lead-candidate-lipominus-202-shares-up-29\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255683\" data-ts=\"1491405185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255683-jpmorgan-says-sales-expectations-for-shires-dry-eye-drug-xiidra-too-high-shares-ease-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan says sales expectations for Shire&#39;s dry eye drug Xiidra too high; shares ease 1%</a></h4><ul><li>In a note, JPMorgan says the consensus view of $304M for Shire plc's (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='red'>-1%</font>) eye drop drug <a href=\"https://www.xiidra.com/\" target=\"_blank\">Xiidra </a>(lifitegrast ophthalmic solution) is too bullish. It expects $272M, below Bloomberg's estimate of $297.8M, adding that the results will probably be closer to $240M unless there is an acceleration in repeat prescriptions or more discounting than forecast. Xiidra is still expected to be a blockbuster by the end of the decade.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3255683\" data-linked=\"JPMorgan says sales expectations for Shire&#39;s dry eye drug Xiidra too high; shares ease 1%\" data-tweet=\"$SHPG - JPMorgan says sales expectations for Shire&#39;s dry eye drug Xiidra too high; shares ease 1% https://seekingalpha.com/news/3255683-jpmorgan-says-sales-expectations-for-shires-dry-eye-drug-xiidra-too-high-shares-ease-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3255683-jpmorgan-says-sales-expectations-for-shires-dry-eye-drug-xiidra-too-high-shares-ease-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255668\" data-ts=\"1491404473\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255668-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> NEOT <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals'>CRVS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/UNIS' title='Unilife Corporation'>UNIS</a> <font color='red'>-75%</font>. <a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255668\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$EVFM $INNL $NEOS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3255668-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3255668-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255685\" data-ts=\"1491404171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBAYF\" target=\"_blank\">HBAYF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255685-department-store-stocks-catch-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Department store stocks catch a bid</a></h4><ul> <li>Department store stocks are higher after Hudson's Bay (<a href='https://seekingalpha.com/symbol/HBAYF' title='Hudson&#39;s Bay Co'>OTCPK:HBAYF</a>) management says on a conference  call that acquisitions are still part of its strategy.</li> <li>The company doesn't want to do a deal that materially impacts its debt level, according to Bloomberg.</li> <li>There's also some <a href=\"http://cnafinance.com/macys-m-stock-spikes-on-amazon-amzn-takeover-rumors/14656\" target=\"_blank\">loose chatter</a> circulating about Amazon interest in Macy's.</li> <li>Sector watch:&nbsp;Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='green'>+1.9%</font>), J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='green'>+3.5%</font>), Sears Holdings (SHLD <font color='green'>+2.3%</font>), Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='green'>+1.1%</font>), Dillard's (<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a> <font color='green'>+2%</font>), Nordstrom (<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='green'>+0.9%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255685\" data-linked=\"Department store stocks catch a bid\" data-tweet=\"$HBAYF $HBAYF $M - Department store stocks catch a bid https://seekingalpha.com/news/3255685-department-store-stocks-catch-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3255685-department-store-stocks-catch-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255684\" data-ts=\"1491403829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255684-reuters-chinese-miner-in-talks-to-buy-half-of-barrick-golds-veladero-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Chinese miner in talks to buy half of Barrick Gold&#39;s Veladero mine</a></h4><ul>     <li>China's Shandong Gold Mining is <a href=\"http://www.reuters.com/article/us-barrick-veladero-shandong-idUSKBN1771QH\" target=\"_blank\">in advanced talks to purchase</a> a 50% stake in Barrick Gold's (ABX <font color='red'>-1.9%</font>) Veladero gold mine in Argentina, in a deal that could fetch more than $1B, Reuters reports.</li>     <li>ABX&nbsp;is no longer in discussions with China's Zijin Mining (<a href='https://seekingalpha.com/symbol/ZIJMF' title='Zijin Mining Group Company Ltd.'>OTCPK:ZIJMF</a>) about the Veladero mine stake, according to the report.</li>     <li>As part of a plan being discussed, Shandong reportedly also could acquire 50% of ABX's nearby undeveloped Pascua-Lama gold and silver project.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255684\" data-linked=\"Reuters: Chinese miner in talks to buy half of Barrick Gold&#39;s Veladero mine\" data-tweet=\"$GOLD $GOLD $ZIJMF - Reuters: Chinese miner in talks to buy half of Barrick Gold&#39;s Veladero mine https://seekingalpha.com/news/3255684-reuters-chinese-miner-in-talks-to-buy-half-of-barrick-golds-veladero-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3255684-reuters-chinese-miner-in-talks-to-buy-half-of-barrick-golds-veladero-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255682\" data-ts=\"1491403443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255682-intuitive-surgical-perks-up-1-on-takeover-speculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical perks up 1% on takeover speculation</a></h4><ul><li>Intuitive Surgical (<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color='green'>+0.9%</font>) is the latest takeover candidate <em>de jour</em>. Shares are up on light volume.</li><li>With the exception of a Q4 2016 correction, shares have been in a steady uptrend since Q4 2015, climbing over 70% along the way.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255682\" data-linked=\"Intuitive Surgical perks up 1% on takeover speculation\" data-tweet=\"$ISRG - Intuitive Surgical perks up 1% on takeover speculation https://seekingalpha.com/news/3255682-intuitive-surgical-perks-up-1-on-takeover-speculation?source=tweet\" data-url=\"https://seekingalpha.com/news/3255682-intuitive-surgical-perks-up-1-on-takeover-speculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255681\" data-ts=\"1491402775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QSR\" target=\"_blank\">QSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255681-sizing-up-restaurant-sector-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sizing up restaurant sector M&amp;A</a></h4><ul> <li>M&amp;A activity in the restaurant sector could slow down with major players JAB Holdings and Restaurant Brands International (<a href='https://seekingalpha.com/symbol/QSR' title='Restaurant Brands International Inc.'>QSR</a> <font color='green'>+0.8%</font>) digesting pending acquisitions, <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9265068/jab-buys-panera-analyst-foresees-near-term-slowdown-in-r\" target=\"_blank\">notes</a> Longbow analyst Alton Stump.</li> <li>Other deals struck this year include Golden Gate's acquisition of the Bob Evans Farms (<a href='https://seekingalpha.com/symbol/BOBE' title='Bob Evans Farms, Inc.'>BOBE</a> <font color='green'>+0.4%</font>) restaurant business and Darden Restaurants (<a href='https://seekingalpha.com/symbol/DRI' title='Darden Restaurants, Inc.'>DRI</a> <font color='green'>+0.2%</font>) swallowing up Cheddar.</li> <li>Nations Restaurant News' Jonathan Maze <a href=\"https://twitter.com/jonathanmaze/status/849614791442399235\" target=\"_blank\">reminds</a> that Bravo Brio Restaurant Group (<a href='https://seekingalpha.com/symbol/BBRG' title='Bravo Brio Restaurant Group, Inc.'>BBRG</a> <font color='green'>+2.2%</font>), Ruby Tuesday (<a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a> <font color='green'>+2.3%</font>) and Ignite Restaurant Group (IRGT <font color='green'>+15.1%</font>) are also still up for sale.</li> <li>Not everyone is convinced that the M&amp;A activity is over. The list of restaurant chains showing some friskiness today include Noodles (<a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='green'>+2.7%</font>), Wingstop (<a href='https://seekingalpha.com/symbol/WING' title='Wingstop, Inc.'>WING</a> <font color='green'>+1.8%</font>), Zoe's Kitchen (<a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a> <font color='green'>+2.6%</font>), Cheesecake Factory (<a href='https://seekingalpha.com/symbol/CAKE' title='The Cheesecake Factory Incorporated'>CAKE</a> <font color='green'>+1.9%</font>) and Red Robin Gourmet Burgers (<a href='https://seekingalpha.com/symbol/RRGB' title='Red Robin Gourmet Burgers, Inc.'>RRGB</a> <font color='green'>+3%</font>).</li> <li>Related ETF: <a href='https://seekingalpha.com/symbol/MENU' title='USCF Restaurant Leaders ETF'>MENU</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255581-jab-buy-panera-bread-7_5b\" target=\"_blank\">JAB to buy Panera Bread for $7.5B</a> (April 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255639-dunkin-brands-lower-jab-nabs-panera\" target=\"_blank\">Dunkin' Brands lower after JAB nabs Panera</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255681\" data-linked=\"Sizing up restaurant sector M&amp;A\" data-tweet=\"$QSR $QSR $BOBE - Sizing up restaurant sector M&amp;A https://seekingalpha.com/news/3255681-sizing-up-restaurant-sector-m?source=tweet\" data-url=\"https://seekingalpha.com/news/3255681-sizing-up-restaurant-sector-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255680\" data-ts=\"1491402644\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255680-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>+1.6M</strong> barrels vs. -0.44M consensus, +0.9M last week.</li><li>Gasoline <strong>-0.6M</strong> barrels vs. -1.42M consensus, -3.7M last week.</li><li>Distillates <strong>-0.5M</strong> vs. -1.02M consensus, -2.5M last week.</li><li>Futures&nbsp;<font color='green'>+1.47%</font>&nbsp;to $51.78.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3255680\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3255680-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3255680-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255676\" data-ts=\"1491401886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255676-new-tone-of-cooperation-in-indonesia-boosting-freeport-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New tone of cooperation in Indonesia boosting Freeport shares</a></h4><ul>     <li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+1.5%</font>) extends gains following <a href=\"https://seekingalpha.com/news/3255380-indonesia-allows-exports-freeport-mine-temporary-deal\" target=\"_blank\">yesterday's news</a> that it would receive a temporary mining permit in a plan to allow exports to resume at its Grasberg copper mine in Indonesia while discussions on longer-term issues continued.</li>     <li>Grasberg's concentrate exports were halted for 12 weeks since the government first announced the new rules amid tough talk and escalating tensions, but <a href=\"http://www.reuters.com/article/us-indonesia-freeport-idUSKBN1761AP\" target=\"_blank\">the tone has shifted markedly</a> in recent weeks, raising hopes for an amicable settlement.</li>     <li>\"A resumption of exports would be a significant positive for Freeport in the near-term and would make us more optimistic about an eventual agreement over the more difficult longer-term issues,\" says Jefferies analyst Chris LaFemina.</li>     <li>But some analysts have questioned the legal basis of the temporary permit and say the two sides are just kicking the can down the road.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255676\" data-linked=\"New tone of cooperation in Indonesia boosting Freeport shares\" data-tweet=\"$FCX - New tone of cooperation in Indonesia boosting Freeport shares https://seekingalpha.com/news/3255676-new-tone-of-cooperation-in-indonesia-boosting-freeport-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3255676-new-tone-of-cooperation-in-indonesia-boosting-freeport-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255675\" data-ts=\"1491401851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIO\" target=\"_blank\">NBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255675-nascent-biotech-files-ind-for-lead-product-candidate-pritumumab-shares-up-35\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nascent Biotech files IND for lead product candidate pritumumab; shares up 35%</a></h4><ul><li><a href=\"http://www.nascentbiotech.com/\" target=\"_blank\">Nascent Biotech</a> (<a href='https://seekingalpha.com/symbol/NBIO' title='Nascent Biotech Inc.'>OTCQB:NBIO</a> <font color='green'>+34.6%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1622057/000147793217001563/nbio_ex99i.htm\" target=\"_blank\">files </a>its Investigational New Drug &#40;IND&#41; application with the FDA for <a href=\"http://www.nascentbiotech.com/products/\" target=\"_blank\">pritumumab</a>, a fully human monoclonal IgG antibody for the potential treatment of brain tumors and other cancers. Clinical trials should commence in the coming months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255675\" data-linked=\"Nascent Biotech files IND for lead product candidate pritumumab; shares up 35%\" data-tweet=\"$NBIO - Nascent Biotech files IND for lead product candidate pritumumab; shares up 35% https://seekingalpha.com/news/3255675-nascent-biotech-files-ind-for-lead-product-candidate-pritumumab-shares-up-35?source=tweet\" data-url=\"https://seekingalpha.com/news/3255675-nascent-biotech-files-ind-for-lead-product-candidate-pritumumab-shares-up-35\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255673\" data-ts=\"1491401311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255673-therapix-bio-nabs-rights-to-nasal-drug-delivery-technology-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix Bio nabs rights to nasal drug delivery technology; shares up 4%</a></h4><ul><li>Therapix Biosciences (<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+3.6%</font>) inks a sublicense <a href=\"https://seekingalpha.com/pr/16791494-therapix-signs-exclusive-license-agreement-yissum-nasal-drug-delivery-technology\" target=\"_blank\">agreement </a>with Hebrew University's Yissum Research Development Company for global exclusive rights to its nasal drug delivery technology for the nasal delivery of cannabinoids.</li><li>The technology facilitates the administration and effective nasal absorption of tetrahydrocannabinol &#40;THC&#41;, the active ingredient in the drugs being developed by Therapix.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255673\" data-linked=\"Therapix Bio nabs rights to nasal drug delivery technology; shares up 4%\" data-tweet=\"$TRPX - Therapix Bio nabs rights to nasal drug delivery technology; shares up 4% https://seekingalpha.com/news/3255673-therapix-bio-nabs-rights-to-nasal-drug-delivery-technology-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3255673-therapix-bio-nabs-rights-to-nasal-drug-delivery-technology-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255671\" data-ts=\"1491401064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255671-carmax-battles-back-after-early-week-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax battles back after early week drop</a></h4><ul> <li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a>) is <font color='green'>up 2.78%</font> in early trading. The <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">word on the street</a> is that M Science is saying that CarMax's Q1 is tracking very strong (same-store sales +8% to +10% vs. +5.0% consensus).</li> <li>Shares of CarMax stumbled earlier this week after Morgan Stanley warned on the bottom dropping out of used car prices.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3254924-sinking-feeling-used-car-market\" target=\"_blank\">A sinking feeling in the used car market</a> (April 1)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3255671\" data-linked=\"CarMax battles back after early week drop\" data-tweet=\"$KMX - CarMax battles back after early week drop https://seekingalpha.com/news/3255671-carmax-battles-back-after-early-week-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3255671-carmax-battles-back-after-early-week-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255652\" data-ts=\"1491399240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECYT\" target=\"_blank\">ECYT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255652-research-suggests-endocytes-smdcs-can-make-car-t-therapy-safer-shares-ahead-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Research suggests that Endocyte&#39;s SMDCs can make CAR-T therapy safer; shares ahead 8% premarket</a></h4><ul><li>Thinly traded micro cap Endocyte (NASDAQ:<a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a>) perks up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16791333-endocyte-presents-data-aacr-identifying-multiple-methods-managing-severe-side-effects\" target=\"_blank\">announcement </a>of new research supporting the value of its small molecule drug conjugates (SMDCs) in reducing the risk of excessive cytokine release in patients receiving CAR-T therapy. The data were presented at the American Association for Cancer Research in Washington, DC.</li><li>Research conducted at Purdue University Center for Drug Discovery showed Endocyte's bi-specific SMDC adaptors can control the rate and extent of CAR T-cell activation by using a bispecific adaptor molecule to mediate engagement of the CAR T-cell with the cancer cell. The approach enables a universal CAR T-cell to bind and kill a cancer cell only when the bispecific adaptor creates a bridge between the two.</li><li>The technology can potentially control a major problem with CAR-T therapies when they work too well. The subsequent over-release of cytokines, called a cytokine storm, can be life-threatening if not controlled.</li><li>The company and Purdue have exclusive agreements in place to research, develop and commercialize SMDC therapeutics and companion imaging agents. Endocyte has exclusive rights to the CAR T-cell and SMDC adaptors for all indications.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255652\" data-linked=\"Research suggests that Endocyte&#39;s SMDCs can make CAR-T therapy safer; shares ahead 8% premarket\" data-tweet=\"$ECYT - Research suggests that Endocyte&#39;s SMDCs can make CAR-T therapy safer; shares ahead 8% premarket https://seekingalpha.com/news/3255652-research-suggests-endocytes-smdcs-can-make-car-t-therapy-safer-shares-ahead-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3255652-research-suggests-endocytes-smdcs-can-make-car-t-therapy-safer-shares-ahead-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255653\" data-ts=\"1491398865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEWR\" target=\"_blank\">NEWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255653-new-relicplus-4_1-on-street-positivity-for-early-q4-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Relic +4.1% on Street positivity for early Q4 numbers</a></h4><ul>   <li>New Relic (NYSE:<a href='https://seekingalpha.com/symbol/NEWR' title='New Relic'>NEWR</a>) is <font color='green'>up 4.1%</font> premarket after posting <a href=\"https://seekingalpha.com/pr/16790804-new-relic-announces-strong-preliminary-results-fourth-quarter-fiscal-2017\" target=\"_blank\">preliminary results</a> for its Q4 that forecast record deferred revenue and an eventual break-even on operations at the end of next fiscal year.</li>    <li>The company sees Q4 revenues of $73M-$73.1M, up from previous guidance for $70.3M-$71.3M.</li>    <li>Cowen's J. Derrick Wood expects favorable tailwinds for the company, including growing traction from its new Server product as well as rising demand for APM tools, and boosts his target to $47 from $44, implying 27% upside.</li>    <li>The company said that its president and head of sales, Hilarie Koplow-McAdams, would retire in mid-June, and that Q4 saw its largest-ever transaction: a three-year, $24M contract value agreement with an existing Fortune 100 customer who would deploy the full platform.</li>    <li>Goldman Sachs' Jesse Hulsing notes Koplow-McAdams' departure adds some execution risk, but says the big deal as a positive data point in a key point of debate on New Relic (enterprise momentum) and boosts the firm's target to $35 from $33 (New Relic closed at $37.06 yesterday).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255653\" data-linked=\"New Relic +4.1% on Street positivity for early Q4 numbers\" data-tweet=\"$NEWR - New Relic +4.1% on Street positivity for early Q4 numbers https://seekingalpha.com/news/3255653-new-relicplus-4_1-on-street-positivity-for-early-q4-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3255653-new-relicplus-4_1-on-street-positivity-for-early-q4-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255649\" data-ts=\"1491398758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255649-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+72%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16791172-plug-power-amazon-sign-agreement-multi-site-genkey-deployments\" target=\"_blank\">signing</a> Amazon Agreement for Multi-Site GenKey Deployments.</li>     <li>NEOT <font color='green'>+50%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16791325-neothetics-announces-issuance-uspto-eighth-patent-directed-lipominus-202-lead-clinical-asset\" target=\"_blank\">issuance</a> of&nbsp;U.S.&nbsp;Patent Number 9,597,531 by the United States Patent and Trademark Office.</li>     <li><a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='green'>+33% </font>on&nbsp;<a href=\"https://seekingalpha.com/pr/16790999-gurnet-point-l-p-enters-agreement-acquire-innocoll-holdings-plc\" target=\"_blank\">acquiring</a> Innocoll Holdings plc.</li>     <li><a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='green'>+17%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PNRA' title='Panera Bread Company'>PNRA</a> <font color='green'>+13%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16791088-panera-bread-jab-announce-definitive-merger-agreement\" target=\"_blank\">merger</a> Agreement with JAB</li><li><a href='https://seekingalpha.com/symbol/VICL' title='Vical Incorporated'>VICL</a> <font color='green'>+11%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color='green'>+9%</font>&nbsp;on signing more than $1.0B agreement with Mitsubishi UFJ Lease &amp; Finance.</li>     <li><a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+8%</font>&nbsp;on signing Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology.</li>     <li><a href='https://seekingalpha.com/symbol/CALI' title='China Auto Logistics Inc.'>OTC:CALI</a> <font color='green'>+8% on&nbsp;</font><a href=\"https://seekingalpha.com/pr/16791222-mack-cali-announces-senior-management-changes\" target=\"_blank\">senior</a>&nbsp;management changes.</li>     <li><a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals'>CRVS</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='green'>+6%&nbsp;</font>     on <a href=\"https://seekingalpha.com/pr/16791429-corbus-pharmaceuticals-commence-single-phase-3-study-anabasum-treatment-systemic-sclerosis\" target=\"_blank\">commencing</a>&nbsp;single phase 3 Study of anabasum for treatment of systemic sclerosis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255649\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$PLUG $EVFM $INNL - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3255649-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3255649-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255647\" data-ts=\"1491398265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255647-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='red'>-13%</font>&nbsp;on modern Capesize vessel acquisition.</li><li><a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a> <font color='red'>-11%</font>&nbsp;on underwriting offering of ordinary shares.</li><li><a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/BNTC' title='Benitec'>BNTC</a> <font color='red'>-7%</font>&nbsp;on preclinical data from BB-301.</li><li><a href='https://seekingalpha.com/symbol/PSO' title='Pearson plc'>PSO</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3255647\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$SHIP $QTNT $TOPS - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3255647-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3255647-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255645\" data-ts=\"1491397856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAXN\" target=\"_blank\">AAXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255645-taser-up-nearly-5-ahead-of-big-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taser up nearly 5% ahead of big announcement</a></h4><ul><li>The company <a href=\"https://www.axon.io/info/future\" target=\"_blank\">plans a live broadcast </a>with CEO Rick Smith at noon ET to announce&nbsp;&ldquo;the biggest news in our company&rsquo;s history.\"</li><li>TASR&nbsp;<font color='green'>+4.6%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3255645\" data-linked=\"Taser up nearly 5% ahead of big announcement\" data-tweet=\"$AAXN - Taser up nearly 5% ahead of big announcement https://seekingalpha.com/news/3255645-taser-up-nearly-5-ahead-of-big-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/3255645-taser-up-nearly-5-ahead-of-big-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255643\" data-ts=\"1491397627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255643-argus-points-to-positive-trends-wynn-resorts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argus points to positive trends at Wynn Resorts</a></h4><ul> <li>Argus lifts Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) to a Buy rating after having the casino operator set at Hold.</li> <li>\"Despite stiff competition, results at the Wynn Palace in Macau, which opened in August 2016, have shown consistent improvement, with occupancy and room rates both rising in the fourth quarter,\" writes analyst John Staszak.</li> <li>He also thinks positive trends in Las Vegas will help to boost earnings growth.</li> <li>The investment firm assigns a price target of $135 to the stock off of estimates for 2017 EPS of $4.30 and 2018 EPS of $5.00.</li> <li>Sources: Bloomberg and Benzinga</li> <li>WYNN <font color='green'>+1.29%</font> premarket to $118.25.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3255643\" data-linked=\"Argus points to positive trends at Wynn Resorts\" data-tweet=\"$WYNN - Argus points to positive trends at Wynn Resorts https://seekingalpha.com/news/3255643-argus-points-to-positive-trends-wynn-resorts?source=tweet\" data-url=\"https://seekingalpha.com/news/3255643-argus-points-to-positive-trends-wynn-resorts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255642\" data-ts=\"1491397296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEOS\" target=\"_blank\">NEOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255642-cowen-likes-neos-therapeutics-sees-178-upside-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen likes Neos Therapeutics, sees 178% upside; shares ahead 7% premarket</a></h4><ul><li>Thinly traded micro cap Neos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NEOS' title='Neos Therapeutics'>NEOS</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume on the heels of a bullish call from Cowen and Company. Analyst Tyler Van Buren rates the stock Outperform with a $20 (178% upside) price target on the basis of stabilizing execution and value-stoking prospects from Tussionex and Adzeny XR-ODT.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3255642\" data-linked=\"Cowen likes Neos Therapeutics, sees 178% upside; shares ahead 7% premarket\" data-tweet=\"$NEOS - Cowen likes Neos Therapeutics, sees 178% upside; shares ahead 7% premarket https://seekingalpha.com/news/3255642-cowen-likes-neos-therapeutics-sees-178-upside-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3255642-cowen-likes-neos-therapeutics-sees-178-upside-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255639\" data-ts=\"1491397123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNKN\" target=\"_blank\">DNKN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255639-dunkin-brands-lower-after-jab-nabs-panera\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dunkin&#39; Brands lower after JAB nabs Panera</a></h4><ul> <li>Shares of Dunkin' Brands Group (NASDAQ:<a href='https://seekingalpha.com/symbol/DNKN' title='Dunkin&#39; Brands'>DNKN</a>) are <font color='red'>down 2.25%</font> in premarket trading after JAB Holding acquires Panera Bread.</li> <li>Dunkin' has been a rumored target of JAB in the past.</li> <li>JAB already owns the Krispy Kreme business.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255581-jab-buy-panera-bread-7_5b\" target=\"_blank\">JAB to buy Panera Bread for $7.5B</a> (April 5)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3255639\" data-linked=\"Dunkin&#39; Brands lower after JAB nabs Panera\" data-tweet=\"$DNKN - Dunkin&#39; Brands lower after JAB nabs Panera https://seekingalpha.com/news/3255639-dunkin-brands-lower-after-jab-nabs-panera?source=tweet\" data-url=\"https://seekingalpha.com/news/3255639-dunkin-brands-lower-after-jab-nabs-panera\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255638\" data-ts=\"1491396756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MON\" target=\"_blank\">MON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255638-monsantoplus-1_6-after-fq2-beat-sees-ful-year-eps-high-end-of-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monsanto +1.6% after FQ2 beat; sees ful-year EPS at high end of guidance</a></h4><ul>     <li>Monsanto (NYSE:<a href='https://seekingalpha.com/symbol/MON' title='Monsanto Company'>MON</a>)&nbsp;<font color='green'>+1.6%</font> premarket after reporting solid <a href=\"https://seekingalpha.com/news/3255615-monsanto-beats-0_40-beats-revenue\" target=\"_blank\">FQ2 earnings</a> and revenue beats,  amid signs that U.S. farmers are preparing to <a href=\"https://www.bloomberg.com/news/articles/2017-04-05/monsanto-earnings-beat-estimates-as-u-s-seed-sales-climb\" target=\"_blank\">sow a record acreage with soybeans</a> this year.</li>     <li>MON says FQ2 corn seed and traits sales totaled $2.9B vs. analyst consensus of $2.73B, and soybean seed and traits sales were $862M vs. $857M consensus.</li>     <li>MON also forecasts FY 2017 EPS at the high end of previously announced guidance of $4.50-$4.90, which would beat analyst consensus $4.76.</li>     <li>Total corn, soybean and cotton acreage in the U.S. is projected to rise by 2.2% this year, which is positive for MON, Susquehanna analysts say.</li><li>MON says it continues to work toward completion of its merger with Bayer by the end of calendar year 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255638\" data-linked=\"Monsanto +1.6% after FQ2 beat; sees ful-year EPS at high end of guidance\" data-tweet=\"$MON - Monsanto +1.6% after FQ2 beat; sees ful-year EPS at high end of guidance https://seekingalpha.com/news/3255638-monsantoplus-1_6-after-fq2-beat-sees-ful-year-eps-high-end-of-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3255638-monsantoplus-1_6-after-fq2-beat-sees-ful-year-eps-high-end-of-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255637\" data-ts=\"1491396676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRBP\" target=\"_blank\">CRBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255637-fda-ok-single-pivotal-study-to-support-nda-for-corbus-pharmas-anabasum-shares-ahead-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OK with single pivotal study to support NDA for Corbus Pharma&#39;s anabasum; shares ahead 9% premarket</a></h4><ul><li>Corbus Pharmaceuticals Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;premarket on higher-than-normal volume in response to its <a href=\"https://seekingalpha.com/pr/16791429-corbus-pharmaceuticals-commence-single-phase-3-study-anabasum-treatment-systemic-sclerosis\" target=\"_blank\">announcement </a>that the FDA has agreed that one Phase 3 clinical trial assessing anabasum (Resunab) for the treatment of diffuse cutaneous systemic sclerosis will be sufficient to support a New Drug Application &#40;NDA&#41;. Enrollment should commence in Q4.</li><li><a href=\"http://www.corbuspharma.com/product-pipeline/resunab\" target=\"_blank\">Resunab</a>, also in development for cystic fibrosis and dermatomyositis, is an oral synthetic endocannabinoid-mimetic that preferentially binds to the&nbsp;<a href=\"https://en.wikipedia.org/wiki/Cannabinoid_receptor_type_2\" target=\"_blank\">cannabinoid receptor type 2</a>&nbsp;(CB2) expressed on activated immune cells and&nbsp;<a href=\"https://en.wikipedia.org/wiki/Fibroblast\" target=\"_blank\">fibroblasts</a>. Activating CB2 triggers biochemical pathways that halt fibrosis and inflammation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255637\" data-linked=\"FDA OK with single pivotal study to support NDA for Corbus Pharma&#39;s anabasum; shares ahead 9% premarket\" data-tweet=\"$CRBP - FDA OK with single pivotal study to support NDA for Corbus Pharma&#39;s anabasum; shares ahead 9% premarket https://seekingalpha.com/news/3255637-fda-ok-single-pivotal-study-to-support-nda-for-corbus-pharmas-anabasum-shares-ahead-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3255637-fda-ok-single-pivotal-study-to-support-nda-for-corbus-pharmas-anabasum-shares-ahead-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255636\" data-ts=\"1491396558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLDP\" target=\"_blank\">BLDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255636-ballard-powerplus-7-fuelcellplus-12-after-plug-power-amazon-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ballard Power +7%, FuelCell +12% after Plug Power/Amazon deal</a></h4><ul><li>Plug Power is&nbsp;<font color='green'>higher by 65%</font>&nbsp;after inking a deal to supply fuel cells and hydrogen technology for Amazon's fulfillment network.</li><li><a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a>&nbsp;<font color='green'>+7.7%</font>, <a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a>&nbsp;<font color='green'>+12.7%</font>&nbsp;premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255610-plug-rockets-amazon-deal\" target=\"_blank\">Plug rockets on Amazon deal</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255636\" data-linked=\"Ballard Power +7%, FuelCell +12% after Plug Power/Amazon deal\" data-tweet=\"$BLDP $BLDP $FCEL - Ballard Power +7%, FuelCell +12% after Plug Power/Amazon deal https://seekingalpha.com/news/3255636-ballard-powerplus-7-fuelcellplus-12-after-plug-power-amazon-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3255636-ballard-powerplus-7-fuelcellplus-12-after-plug-power-amazon-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255633\" data-ts=\"1491396076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNCE\" target=\"_blank\">CNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255633-delay-in-start-of-concert-pharmas-mid-stage-study-of-ctpminus-543-sinks-shares-down-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delay in start of Concert Pharma&#39;s mid-stage study of CTP-543 sinks shares, down 8% premarket</a></h4><ul><li>Concert Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a>) is down&nbsp;<font color='red'>8%</font>&nbsp;premarket, albeit on only 890 shares, in response to its <a href=\"https://seekingalpha.com/filing/3492006\" target=\"_blank\">announcement </a>of a delay in initiating its Phase 2a clinical trial evaluating CTP-543 in alopecia areata (autoimmune disorder that causes hair loss). The study was supposed to start this quarter.</li><li>The problem apparently relates to the appearance of the tablets that will be used in the trial. The company says it is working to address the issue and expects the study to commence this year. Top-line data should be available in Q1 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255633\" data-linked=\"Delay in start of Concert Pharma&#39;s mid-stage study of CTP-543 sinks shares, down 8% premarket\" data-tweet=\"$CNCE - Delay in start of Concert Pharma&#39;s mid-stage study of CTP-543 sinks shares, down 8% premarket https://seekingalpha.com/news/3255633-delay-in-start-of-concert-pharmas-mid-stage-study-of-ctpminus-543-sinks-shares-down-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3255633-delay-in-start-of-concert-pharmas-mid-stage-study-of-ctpminus-543-sinks-shares-down-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255627\" data-ts=\"1491395467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VICL\" target=\"_blank\">VICL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255627-vical-inks-hep-b-research-deal-anges-mg-shares-ahead-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vical inks hep B research deal with AnGes MG; shares ahead 11% premarket</a></h4><ul><li>Thinly traded nano cap Vical (NASDAQ:<a href='https://seekingalpha.com/symbol/VICL' title='Vical Incorporated'>VICL</a>) perks up&nbsp;<font color='green'>11%</font>&nbsp;premarket on higher-than-normal volume in response to its <a href=\"https://seekingalpha.com/filing/3490155\" target=\"_blank\">announcement </a>of a research collaboration with AnGes MG under which AnGes will fund preclinical research related to a development program targeting chronic hepatitis B infection. In exchange for the funding, AnGes will have the option to negotiate exclusive rights in Japan.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255627\" data-linked=\"Vical inks hep B research deal with AnGes MG; shares ahead 11% premarket\" data-tweet=\"$VICL $BBI - Vical inks hep B research deal with AnGes MG; shares ahead 11% premarket https://seekingalpha.com/news/3255627-vical-inks-hep-b-research-deal-anges-mg-shares-ahead-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3255627-vical-inks-hep-b-research-deal-anges-mg-shares-ahead-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255628\" data-ts=\"1491395292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255628-sector-rally-after-amazon-plug-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sector rally after Amazon-Plug deal</a></h4><ul><li><a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='green'>+20%</font>, <a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+11% </font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3255610-plug-rockets-amazon-deal\" target=\"_blank\">Plug rockets on Amazon deal</a> (Apr. 05 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255628\" data-linked=\"Sector rally after Amazon-Plug deal\" data-tweet=\"$FCEL $FCEL $BLDP - Sector rally after Amazon-Plug deal https://seekingalpha.com/news/3255628-sector-rally-after-amazon-plug-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3255628-sector-rally-after-amazon-plug-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255624\" data-ts=\"1491395045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255624-yields-and-dollar-on-rise-after-strong-adp-jobs-print\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yields and dollar on the rise after strong ADP jobs print</a></h4><ul><li>Another blowout number from the ADP - 263K jobs added in March vs. 170K expected - has the 10-year Treasury yield up about two basis points to 2.37%, and the dollar index higher by 0.1% (was in the red prior to the report).</li><li><a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-0.3%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a> flat premarket</li><li>Tempering this morning's strong number is February's originally-reported whopper of a 298K job gain being revised lower to 245K.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3255620-u-s-economy-added-263k-jobs-february\" target=\"_blank\">U.S. Economy added 263K jobs in February</a> (April 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255624\" data-linked=\"Yields and dollar on the rise after strong ADP jobs print\" data-tweet=\"$TLT $TBT $UUP - Yields and dollar on the rise after strong ADP jobs print https://seekingalpha.com/news/3255624-yields-and-dollar-on-rise-after-strong-adp-jobs-print?source=tweet\" data-url=\"https://seekingalpha.com/news/3255624-yields-and-dollar-on-rise-after-strong-adp-jobs-print\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255613\" data-ts=\"1491393885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MZOR\" target=\"_blank\">MZOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255613-mazor-robotics-q1-top-line-expected-to-be-11_5m-receives-purchase-orders-for-six-mazor-x\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mazor Robotics Q1 top-line expected to be ~$11.5M; receives purchase orders for six Mazor X Systems</a></h4><ul> <li>Mazor Robotics (<a href='https://seekingalpha.com/symbol/MZOR' title='Mazor Robotics Ltd.'>MZOR</a>) <a href=\"https://seekingalpha.com/pr/16791054-mazor-robotics-expects-report-record-first-quarter-revenue-approximately-11_5-million\" target=\"_blank\">announces</a> that driven       by the strength in Mazor X system sales and increased procedure volume,       the Company expects to report record Q1 revenue of       ~$11.5M and received purchase orders for six Mazor X systems in the U.S.&nbsp;In addition, it received a purchase order for a       Renaissance brain module upgrade in the international market.</li>          <li>Mazor ended Q1 with a backlog of 14 Mazor X systems and       the Company expects to deliver these systems in 2017. Q1 results are expected to be released in May.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3255613\" data-linked=\"Mazor Robotics Q1 top-line expected to be ~$11.5M; receives purchase orders for six Mazor X Systems\" data-tweet=\"$MZOR - Mazor Robotics Q1 top-line expected to be ~$11.5M; receives purchase orders for six Mazor X Systems https://seekingalpha.com/news/3255613-mazor-robotics-q1-top-line-expected-to-be-11_5m-receives-purchase-orders-for-six-mazor-x?source=tweet\" data-url=\"https://seekingalpha.com/news/3255613-mazor-robotics-q1-top-line-expected-to-be-11_5m-receives-purchase-orders-for-six-mazor-x\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255612\" data-ts=\"1491393488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255612-weidman-time-nearing-for-ecb-to-step-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weidman: Time nearing for ECB to step back</a></h4><ul><li>It's just Germans being Germans, but nevertheless the euro has added a few pips and European bond yields have gained a bit after Bundesbank chief Jens Weidman says the time is approaching for the ECB to step back.</li><li>The euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>) is back to about level on the day vs. the dollar at $1.0680, and long-dated yields are all about one basis point higher across the EU.</li><li>In stocks, most of Europe is modestly higher, but Germany (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWG' title='iShares MSCI Germany ETF'>EWG</a>) is an outlier -&nbsp;<font color='red'>down 0.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255612\" data-linked=\"Weidman: Time nearing for ECB to step back\" data-tweet=\"$FXE $EWG - Weidman: Time nearing for ECB to step back https://seekingalpha.com/news/3255612-weidman-time-nearing-for-ecb-to-step-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3255612-weidman-time-nearing-for-ecb-to-step-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255611\" data-ts=\"1491393301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255611-redhill-nabs-exclusive-u-s-rights-to-enteragram-shares-ahead-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill nabs exclusive U.S. rights to EnteraGram; shares ahead 3% premarket</a></h4><ul><li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) inks an <a href=\"https://seekingalpha.com/pr/16791176-redhill-biopharma-announces-exclusive-u-s-license-entera-health-commercial-gi-product\" target=\"_blank\">agreement </a>with privately held Entera Health for the exclusive U.S. rights to EnteraGram, a medical food for the dietary management of chronic diarrhea and loose stools that is administered under medical supervision. It currently generates over $5M in annual sales.</li><li>EnteraGram is a serum-derived bovine immunoglobulin/protein isolate that restores gut balance.</li><li>Under the terms of the agreement, RedHill will pay Entera tiered royalties on net sales of EnteraGram. It will also receive certain U.S. rights to dicyclomine hydrochloride oral solution, an antispasmodic and anticholinergic agent for the treatment of functional bowel/irritable bowel syndrome.</li><li>Chief Business Officer Guy Goldberg says, \"We look forward to initiating the promotion of Donnatal<sup>&reg;4</sup>&nbsp;and EnteraGam<sup>&reg;</sup>&nbsp;in mid-2017. We are currently in advanced stages of building RedHill&rsquo;s commercial operations in the U.S. and are excited to complement our product portfolio with a second commercial product geared towards gastroenterologists. We would like to thank our new partners at Entera Health and look forward to a successful long-term partnership.&rdquo;</li><li>Shares are up&nbsp;<font color='green'>3%&nbsp;</font>premarket albeit on only 340 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255611\" data-linked=\"RedHill nabs exclusive U.S. rights to EnteraGram; shares ahead 3% premarket\" data-tweet=\"$RDHL - RedHill nabs exclusive U.S. rights to EnteraGram; shares ahead 3% premarket https://seekingalpha.com/news/3255611-redhill-nabs-exclusive-u-s-rights-to-enteragram-shares-ahead-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3255611-redhill-nabs-exclusive-u-s-rights-to-enteragram-shares-ahead-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255610\" data-ts=\"1491393274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255610-plug-rockets-on-amazon-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plug rockets on Amazon deal</a></h4><ul><li>Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) has <a href=\"https://seekingalpha.com/pr/16791172-plug-power-amazon-sign-agreement-multi-site-genkey-deployments\" target=\"_blank\">acquired</a> the right to buy up to 23% of Plug Power (NASDAQ:<a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a>), in a deal giving it powerful batteries that promise to speed up work in its fulfillment centers.</li><li>The retailer must spend at least $600M over the life of its contract with Plug Power for its warrants to fully vest.</li><li><a href=\"https://event.webcasts.com/starthere.jsp?ei=1139277\" target=\"_blank\">Conference call</a> at 8:30 a.m. ET</li><li>PLUG <font color='green'>+88%</font> premarket to $2.44/share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3255610\" data-linked=\"Plug rockets on Amazon deal\" data-tweet=\"$AMZN $AMZN $PLUG - Plug rockets on Amazon deal https://seekingalpha.com/news/3255610-plug-rockets-on-amazon-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3255610-plug-rockets-on-amazon-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255592\" data-ts=\"1491390954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255592-acorda-restructures-cuts-headcount-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda restructures, cuts headcount 20%</a></h4><ul><li>Prompted by the adverse AMPYRA patent ruling, Acorda Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a>) announces a <a href=\"https://seekingalpha.com/pr/16791080-acorda-therapeutics-implements-corporate-restructuring-align-cost-structure-focus-promising\" target=\"_blank\">restructuring plan</a> that will enable it to focus its resources on two late-stage programs: CVT-301 and tozadenant.</li><li>The initiative includes the elimination of 20% of its headcount, expected to save ~$21M in annualized expenses. The majority of the cuts will be completed this month. It will book ~$8M in pre-tax charges this quarter for severance and other costs.</li><li>The company expects to be cash flow positive this year. Its quick asset balance was ~$159M at the end of 2016. It expects to have sufficient resources to fund operations through the commercial launch of CVT-301 (NDA to be filed this quarter) and Phase 3 data for tozadenant.</li><li>CEO Ron Cohen, M.D. says, &ldquo;The cost reductions resulting from this restructuring will enable Acorda to continue to advance our two valuable late-stage programs for Parkinson&rsquo;s disease, CVT-301 and tozadenant. Over the last several years, we have strategically diversified our portfolio, and we believe that CVT-301 and tozadenant can be a platform for significant future growth. We believe that the steps that we are taking will position Acorda to deliver long-term value for our shareholders.&rdquo;</li><li>Management will provide updated financial guidance for 2017 during its Q1 conference call.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254831-court-invalidates-four-ampyra-patents-acorda-plummets-24-percent\" target=\"_blank\">Court invalidates four Ampyra patents; Acorda plummets 24%</a> (March 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3255592\" data-linked=\"Acorda restructures, cuts headcount 20%\" data-tweet=\"$ACOR - Acorda restructures, cuts headcount 20% https://seekingalpha.com/news/3255592-acorda-restructures-cuts-headcount-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3255592-acorda-restructures-cuts-headcount-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3255581\" data-ts=\"1491388172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNRA\" target=\"_blank\">PNRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3255581-jab-to-buy-panera-bread-for-7_5b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JAB to buy Panera Bread for $7.5B</a></h4><ul><li>Expanding its coffee and breakfast empire, JAB has agreed to <a href=\"https://seekingalpha.com/pr/16791088-panera-bread-jab-announce-definitive-merger-agreement\" target=\"_blank\">acquire</a> Panera Bread (NASDAQ:<a href='https://seekingalpha.com/symbol/PNRA' title='Panera Bread Company'>PNRA</a>) for $315/share in cash, valuing the deal at approximately $7.5B, including the assumption of approximately $340M of net debt.</li><li>Following the close of the transaction, Panera will be privately held and continue to be operated independently by the company's management team.</li><li>PNRA <font color='green'>+13%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3255581\" data-linked=\"JAB to buy Panera Bread for $7.5B\" data-tweet=\"$PNRA - JAB to buy Panera Bread for $7.5B https://seekingalpha.com/news/3255581-jab-to-buy-panera-bread-for-7_5b?source=tweet\" data-url=\"https://seekingalpha.com/news/3255581-jab-to-buy-panera-bread-for-7_5b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":62,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}